The effect of letrozole and N-acetylcysteine in the treatment of infertility in patients with polycystic ovary syndrome - Trial IRCT20221019056244N1
Access comprehensive clinical trial information for IRCT20221019056244N1 through Pure Global AI's free database. This Phase 2 trial is sponsored by Tabriz University of Medical Sciences and is currently Recruiting. The study focuses on Polycystic ovarian syndrome.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
IRCT20221019056244N1
Phase 2
Recruiting
drug
Trial Details
Iranian Registry Of Clinical Trial • IRCT20221019056244N1
The effect of letrozole and N-acetylcysteine in the treatment of infertility in patients with polycystic ovary syndrome
Comparison of the effect of letrozole with N-acetylcysteine on the expression levels of genes involved in glucose metabolism and the proliferation of cumulus cells in patients with polycystic ovarian syndrome.
Study Focus
Sponsor & Location
Tabriz University of Medical Sciences
Iran
Timeline & Enrollment
Phase 2
Mar 21, 2023
N/A
ICD-10 Classifications
Polycystic ovarian syndrome
Ovarian dysfunction, unspecified
Ovarian dysfunction
Other ovarian dysfunction
Other and unspecified ovarian cysts
Data Source
Iranian Registry Of Clinical Trial
IRCT20221019056244N1
Non-Device Trial